Origin Pharma Packaging opens new UK warehouse in significant capacity expansion
New site includes warehouse maagement system which packaging firm claims will increase picking accuracy and efficiency
Origin Pharma Packaging has opened a new warehouse facility in Scunthorpe, UK, significantly expanding its overall storage capacity for pharmaceutical customers as well as its own manufactured products.
The new 86,000 sq. ft facility is set within a 5.9-acre site, houses 4,900 fully barcoded pallet spaces, a 20,000 sq. ft holding area and four loading bays and expands on Origin’s 25,000 sq. ft logistics warehouse in Melton, UK.
The facility – which Origin said is already fully functioning -- is also equipped with a Warehouse Management System, increasing pick accuracy, stock management and efficiency.
Origin said that by investing in larger warehouse capacity, it will be able to create a more efficient pharma packaging supply chain in the long term and protect against delays caused by the UK’s withdrawal from the European Union (Brexit) and the ongoing COVID-19 pandemic in the short term.
“It will also help the company serve a growing client base who are seeking ISO 15378 pharma standard storage space,” Origin said.
Pharmaceutical and medical device primary packaging materials – which include glass, rubber, plastics, aluminium containers/components, films, foils and laminate containers -- come in direct contact with medicinal products and so need to comply with safety, efficacy and reliability requirements, which include the conditions under which they are stored and transported.
The new warehouse is also supporting local job creation in North Lincolnshire, with Origin recruiting and expanding its on-site operation team. The warehouse is now fully functioning and all staff, along with visitors, are following strict COVID-19 rules and procedures – including social distancing, wearing PPE, temperature checks on arrival and track and trace.
“Origin’s new warehouse facility marks an important milestone for the company, supporting our ambitious growth plans and securing Origin’s long-term position as a market-leading partner to the UK and international pharmaceutical industry,” said Stewart Berry, Operations Lead at Origin.
Related News
-
News Women in Pharma: Hiring Across the Gender Divide
In our monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Big Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pe... -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News Updated – Changing abortion pill access according to the US FDA and Supreme Court
After the approval of the medical abortion pill, mifepristone, by the US FDA, states across the USA approach the distribution of the pill differently, some ruling against allowing access to the drug. -
News Revolutionising cancer treatment with mRNA-based therapeutics
Global market for mRNA-based oncology therapeutics expected to reach USD $2 billion by 2029, with promising results for the combination of mRNA candidates with immune checkpoint inhibitors to treat solid tumours. -
News Breaking Barriers: Innovations in Oral Solid Dose Form Bioavailability
The effectiveness of a medication often hinges on its bioavailability – the rate and extent at which the active ingredient is absorbed into the bloodstream. When it comes to oral solid dose forms, such as tablets and capsules, the challenge lies ... -
News Choosing the Right CDMO Partner: A Comprehensive Guide
Finding the right partner for the development and manufacturing of your pharmaceutical or biopharmaceutical products is paramount. This is where Contract Development and Manufacturing Organizations (CDMOs) step in, offering their expertise and infrastr...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance